KNUST Lab Engineers AI-Powered Assistive Tools to Bridge Healthcare Gaps for Disabled Patients

According to Tech Review Africa, the Responsible AI Lab at Ghana's Kwame Nkrumah University of Science and Technology is engineering a portfolio of assistive technologies designed to close communication gaps between patients with disabilities and the country's healthcare system. The initiative spans sign language translation, smartphone tools for independent phone calls, and AI-enhanced mobility and hearing devices—each co-developed with the communities it targets. The work reframes a foundational problem: how to ensure that the act of seeking medical care does not depend on the presence of an interpreter, a caregiver, or luck.

Inside the toolkit

The flagship project is SignTalk, a system that converts Ghanaian Sign Language between patients and clinicians through an avatar-based interpreter. SignConnect Ghana extends the same logic to telephony, giving deaf users a mobile application to place calls independently. I-See, an AI-powered smart white cane, and I-Hear, an AI-driven hearing aid, round out the assistive lineup. Parallel to these patient-facing tools, RAIL is also building AI solutions for rare disease diagnosis and affordable medical imaging—applications where automation could shift diagnostic capacity into clinics that have never had it.

Built with, not for

The lab frames the program as part of its Inclusive Futures campaign, a deliberate methodology of designing assistive technology alongside the disability community rather than on its behalf. That choice reshapes the validation cycle: features are tested by the people who will use them, which compresses the usual gap between prototype and clinical deployment. The success metric shifts accordingly—from feature counts in a demo to functional independence during a real patient encounter. The lab's stated bet is straightforward: participatory design reduces late-stage rework and yields tools that survive contact with actual clinical environments.

What to watch next

The next milestones will live outside the lab. The proof points are whether SignTalk holds up in busy clinical workflows, whether SignConnect Ghana scales across telecom carriers, and whether the imaging and rare-disease models perform reliably under the bandwidth and equipment constraints typical of regional hospitals. If those checks land, the model becomes exportable: a template for deploying AI access infrastructure in any health system where the first bottleneck is not equipment, but the ability to be understood.